The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments

摘要

Renin–angiotensin system inhibition (RAS) by Angiotensin-converting enzyme/Ang-II receptor blockers (ACEI/ARBs) and SARS-CoV-2 binding to ACE2 receptors. Red squares indicate RAS actions, green squares indicate ACE actions. Black squares indicate effects for each component